Author: Lu, Jinghua; Sun, Peter D; Sun, Peter D.
Title: High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity. Cord-id: sohyuvwk Document date: 2020_12_25
ID: sohyuvwk
Snippet: The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has emerged to a pandemic and caused global public health crisis. Human angiotensin-converting enzyme 2(ACE2) was identified as the entry receptor for SARS-CoV-2. As a carboxypeptidase, ACE2 cleaves many biological substrates besides angiotensin II to control vasodilatation and vascular permeability. Given the nanomolar high affinity between ACE2 and SARS-CoV-2 spike protein, we investigated how this interaction would affect th
Document: The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has emerged to a pandemic and caused global public health crisis. Human angiotensin-converting enzyme 2(ACE2) was identified as the entry receptor for SARS-CoV-2. As a carboxypeptidase, ACE2 cleaves many biological substrates besides angiotensin II to control vasodilatation and vascular permeability. Given the nanomolar high affinity between ACE2 and SARS-CoV-2 spike protein, we investigated how this interaction would affect the enzymatic activity of ACE2. Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ∼3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog. The enhancement in ACE2 enzymatic function was mediated by the binding of SARS-CoV-2 spike RBD domain. These results highlighted the potential for SARS-CoV-2 infection to enhance ACE2 activity, which may be relevant to the cardiovascular symptoms associated with COVID-19.
Search related documents:
Co phrase search for related documents- absence presence and active peptide: 1
- absence presence and active site: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absence presence and lung fluid: 1
- absence presence and lysine residue: 1
- ace angiotensin convert enzyme and acute sars respiratory syndrome coronavirus: 1
- active conformation and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
- active peptide and acute sars respiratory syndrome coronavirus: 1, 2, 3
- active site and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active site and lysine residue: 1, 2
- active site bind and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- active substrate and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- active substrate and lysine residue: 1
- acute sars respiratory syndrome coronavirus and lung fluid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute sars respiratory syndrome coronavirus and lung fluid accumulation: 1, 2
- acute sars respiratory syndrome coronavirus and lung type ii pneumocyte: 1, 2
- acute sars respiratory syndrome coronavirus and lysine residue: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date